SynBiotic SE (DUSE:SBX)
2.230
+0.175 (8.52%)
At close: Mar 9, 2026
SynBiotic SE Revenue
In the year 2023, SynBiotic SE had annual revenue of 3.86M EUR, down -52.71%. SynBiotic SE had revenue of 3.55M in the quarter ending June 30, 2024.
Revenue
3.86M
Revenue Growth
-52.71%
P/S Ratio
3.94
Revenue / Employee
70.21K
Employees
55
Market Cap
15.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.86M | -4.30M | -52.71% |
| Dec 31, 2022 | 8.17M | -898.09K | -9.91% |
| Dec 31, 2021 | 9.06M | 3.59M | 65.63% |
| Dec 31, 2020 | 5.47M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSynBiotic SE News
- 3 months ago - EQS-News: Global momentum in the cannabis market: New signals from the U.S. strengthen long-term prospects for Europe and SYNBIOTIC - Wallstreet:Online
- 4 months ago - Additional capital to support strategic realignment; chg. PT - Wallstreet:Online
- 4 months ago - CANSOUL Invests Strategically in SynBiotic: Stake Acquisition - Wallstreet:Online
- 4 months ago - EQS-News: Strategic Investment: CANSOUL acquires stake in SYNBIOTIC - Wallstreet:Online
- 5 months ago - EQS-News: SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research - Wallstreet:Online
- 6 months ago - EQS-News: SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate - Wallstreet:Online
- 6 months ago - Temporary headwinds from regulatory uncertainty; chg. est. - Wallstreet:Online
- 7 months ago - EQS-News: Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals - Wallstreet:Online